These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35280651)

  • 61. Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.
    Lee HS; Hong H; Jung DC; Park S; Kim J
    Med Phys; 2017 Jul; 44(7):3604-3614. PubMed ID: 28376281
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of a Novel Multiparametric MRI Radiomic Nomogram for Preoperative Evaluation of Early Recurrence in Resectable Pancreatic Cancer.
    Tang TY; Li X; Zhang Q; Guo CX; Zhang XZ; Lao MY; Shen YN; Xiao WB; Ying SH; Sun K; Yu RS; Gao SL; Que RS; Chen W; Huang DB; Pang PP; Bai XL; Liang TB
    J Magn Reson Imaging; 2020 Jul; 52(1):231-245. PubMed ID: 31867839
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pre-operative Prediction of Ki-67 Expression in Various Histological Subtypes of Lung Adenocarcinoma Based on CT Radiomic Features.
    Huang Z; Lyu M; Ai Z; Chen Y; Liang Y; Xiang Z
    Front Surg; 2021; 8():736737. PubMed ID: 34733879
    [No Abstract]   [Full Text] [Related]  

  • 64. The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma.
    Jamshidi N; Jonasch E; Zapala M; Korn RL; Aganovic L; Zhao H; Tumkur Sitaram R; Tibshirani RJ; Banerjee S; Brooks JD; Ljungberg B; Kuo MD
    Radiology; 2015 Oct; 277(1):114-23. PubMed ID: 26402495
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling.
    Yeh AC; Li H; Zhu Y; Zhang J; Khramtsova G; Drukker K; Edwards A; McGregor S; Yoshimatsu T; Zheng Y; Niu Q; Abe H; Mueller J; Conzen S; Ji Y; Giger ML; Olopade OI
    Cancer Imaging; 2019 Jul; 19(1):48. PubMed ID: 31307537
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary renal cell carcinoma: relationship between 18F-FDG uptake and response to neoadjuvant sorafenib.
    Khandani AH; Cowey CL; Moore DT; Gohil H; Rathmell WK
    Nucl Med Commun; 2012 Sep; 33(9):967-73. PubMed ID: 22714005
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Potential of high dimensional radiomic features to assess blood components in intraaortic vessels in non-contrast CT scans.
    Mahmoudi S; Martin SS; Ackermann J; Zhdanovich Y; Koch I; Vogl TJ; Albrecht MH; Lenga L; Bernatz S
    BMC Med Imaging; 2021 Aug; 21(1):123. PubMed ID: 34384385
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes.
    Arefan D; Hausler RM; Sumkin JH; Sun M; Wu S
    BMC Cancer; 2021 Apr; 21(1):370. PubMed ID: 33827490
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
    Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA
    Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects.
    Ferro M; Musi G; Marchioni M; Maggi M; Veccia A; Del Giudice F; Barone B; Crocetto F; Lasorsa F; Antonelli A; Schips L; Autorino R; Busetto GM; Terracciano D; Lucarelli G; Tataru OS
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902045
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study.
    Cianflone F; Lazarevic D; Palmisano A; Fallara G; Larcher A; Freschi M; Dell'Antonio G; Scotti GM; Morelli MJ; Ferrara AM; Trevisani F; Cinque A; Esposito A; Briganti A; Tacchetti C; Doglioni C; Del Maschio A; de Cobelli F; Bertini R; Salonia A; Montorsi F; Tonon G; Capitanio U
    Transl Androl Urol; 2022 Feb; 11(2):149-158. PubMed ID: 35280651
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Radiomic profiling of clear cell renal cell carcinoma reveals subtypes with distinct prognoses and molecular pathways.
    Lin P; Lin YQ; Gao RZ; Wen R; Qin H; He Y; Yang H
    Transl Oncol; 2021 Jul; 14(7):101078. PubMed ID: 33862522
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of radiogenomics in esophageal cancer on clinical outcomes: A pilot study.
    Brancato V; Garbino N; Mannelli L; Aiello M; Salvatore M; Franzese M; Cavaliere C
    World J Gastroenterol; 2021 Sep; 27(36):6110-6127. PubMed ID: 34629823
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Radiogenomics study to predict the nuclear grade of renal clear cell carcinoma.
    He XM; Zhao JX; He DL; Ren JL; Zhao LP; Huang G
    Eur J Radiol Open; 2023; 10():100476. PubMed ID: 36793772
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.